| My Account | Subscribe | Contact Us | Donate |
Home
- The Edmonton Protocol and Me
- Olympia Dukakis and Her Husband Tackle Type 2
- Surfing with Type 1
- Behind the Wheel, But Still in Control
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Insulin Articles
Insulin and Metformin Before Bed Proven Effective for Poorly Controlled Type 2s—Drops HbA1cs from 9.7% to 7.2%
May 1, 1999
In a study conducted in Finland, it was discovered that insulin combined with metformin (Glucophage) taken at bedtime appears to be an effective regimen for controlling type 2 diabetes.
The results of the study were published in the March 2 issue of Annals of Internal Medicine. Finnish investigators report the results of a direct comparison of four bedtime insulin regimens that were randomly assigned to 96 patient with type 2 diabetes. The patients had previously been treated by sulfonylurea therapy alone, and had demonstrated an average HbA1c of 9.9 % and an average BG reading of 214.5 mg/dl.
For 12 months, the 96 patients took a combination of either: (1) bedtime intermediate-acting insulin plus glyburide (10.5 mg.) and placebo, (2) metformin (2 grams) and placebo, (3) glyburide and metformin, or (4) a second injection of intermediate-acting insulin in the morning.
After 13 months, the group taking the combination of intermediate-acting insulin and metformin demonstrated the greatest decrease in HbA1c (9.7 % to 7.2 %). Additionally, this group reported fewer cases of hypoglycemia after one year when compared to the other groups.
Categories: A1c Test, Insulin, Metformin, Type 2 Issues
Facebook
MySpace 
Digg
You May Also Be Interested In...
Click Here To View Or Post Comments
May 1, 1999 -
Email to a Friend
Send a link to this page to your friends and colleagues.